June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Indications and Outcomes for Laser Retinopexy in Patients with Lattice Degeneration
Author Affiliations & Notes
  • Adina S Kazan
    Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States
  • Raziyeh Mahmoudzadeh
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
  • Mirataollah Salabati
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
  • Marc Spirn
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Adina Kazan None; Raziyeh Mahmoudzadeh None; Mirataollah Salabati None; Marc Spirn None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3794 – F0215. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Adina S Kazan, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Marc Spirn; Indications and Outcomes for Laser Retinopexy in Patients with Lattice Degeneration. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3794 – F0215.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the characteristics of eyes with lattice degeneration treated with laser retinopexy and to determine the indications, safety, and outcomes of using laser retinopexy in these eyes.

Methods : Single-center, single-surgeon, consecutive retrospective chart review conducted at Wills Eye Hospital between 2014 and 2021. Comprehensive chart reviews documented characteristics and outcomes of these eyes and fellow eyes.

Results : A total of 158 eyes of 139 patients (58.2% female, mean (±SD) age 50 (±17); range 13-79 years) were included in this study. The mean (±SD) follow-up from the lattice diagnosis visit was 880 (±629; range 46-2183) days. The mean time from lattice diagnosis to initial laser was 77 (±263); range 0-2772) days. The mean (± SD) pre-laser logMAR visual acuity was 0.14 (±.27; Snellen equivalent 20/28) and mean post-laser logMAR visual acuity was 0.12 (±.26; Snellen equivalent 20/26, p=0.157). Indications for laser retinopexy were as follows: 54 eyes (35.3%) had retinal detachment of the fellow eye, 69 eyes (45.1%) had an atrophic hole in the lattice, and 36 eyes (23.5%) had an atrophic hole with subretinal fluid. After laser treatment, 20 eyes (12.8%) developed a new posterior vitreous detachment, 13 eyes (8.2%) developed a new epiretinal membrane, and 6 eyes (3.8%) developed a new retinal detachment. Individuals that developed an epiretinal membrane after laser were more likely to be older (60±8 years v 49±17 years, p=0.018). Additionally, eyes that developed epiretinal membranes after laser were also more likely to develop posterior vitreous detachment (OR=6.143 (1.732-21.788, p=0.002). Of eyes that developed a new epiretinal membrane after laser (n=13), no eyes required surgery to fix the epiretinal membrane. Those that developed retinal detachments were more likely to be older (63±5 years vs. 49±17 years) although this did not reach statistical significance (p=0.054). Of eyes that developed retinal detachments after laser (n=6), 4 eyes were treated with laser retinopexy alone, 2 eyes were treated with scleral buckle and pars plana vitrectomy, and all eyes remained attached up to the final visit with one procedure.

Conclusions : Performing laser retinopexy in eyes at higher risk for progression to retinal detachment does not eliminate the risk of further complications, and routine follow-up is recommended. Older patients also tend to have more ERM formation after laser retinopexy.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×